BridgeBio Soars After Drug Gets Nod in Serious Heart Condition
BridgeBio Pharma Inc. jumped in premarket trading after its drug got US regulators’ nod to treat a deadly form of heart ...
CSR Wire27 分钟
Trailblazing Study Shows Early CGP Leads to Better Precision Treatments
A large, multiyear study conducted by Illumina, Providence, and Microsoft Research has shown that a comprehensive genomic profiling (CGP) panel, which can assess more than 500 genetic variations in ...
Targeted Oncology23 分钟
FDA Approves First Oral Liquid Imatinib for Leukemia and Other Cancers
Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.
Promising Developments and Strategic Positioning Drive Buy Rating for Cartesian Therapeutics
Cartesian Therapeutics (RNAC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum ...
Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion by 2030 ...
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Stem Cell Therapy ...
In the US, young and middle-aged women are being diagnosed with lung cancer at higher rates ...
Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed away in August: “Lung ...
AFP23 分钟
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab ...
Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego. “These ...
Le Lézard32 分钟
PharmaEssentia Announces Nine Data Presentations at ASH Annual Meeting
PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...